Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis

Connie P. Matthews(National Cancer Institute), Nancy H. Colburn(Gene Therapy Laboratory), George R. Beck(Center for Cancer Research), Alyson R. Baker(National Cancer Institute), Alysia M. Birkholz(Center for Cancer Research), Matthew R. Young(NYU Langone Health), Christine M. Perella(National Cancer Institute)
Cancer Research
March 15, 2007
Cited by 46


Related Papers